Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bram Palache"'
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 518-519 (2023)
Externí odkaz:
https://doaj.org/article/808d9cbac4304c2682417cd12b983d8f
Autor:
Bram Palache, Paula Barbosa
Publikováno v:
Internal Medicine Review.
Autor:
Bram Palache
Publikováno v:
Internal Medicine Review. 4
Autor:
Bram Palache
Publikováno v:
Journal of Vaccines & Vaccination.
Publikováno v:
Journal of Knowledge-based Innovation in China. 1:117-142
PurposeMajor technological innovations are usually associated with central R&D facilities in large companies and leading edge technologies that are key to unlocking business opportunities in promising, embryonic markets. The purpose of this paper is
Publikováno v:
Vaccine. 26:D23-D26
Influenza represents a public health paradox. The virus is responsible for significant death, disease and economic loss. However, despite the availability of safe and efficacious vaccines, uptake is poor. While policy makers increasingly recognize th
Publikováno v:
Vaccine. 24:6812-6822
Background In 2003, the World Health Assembly (WHA) issued a resolution for prevention and control of influenza pandemics and annual epidemics, which urges the European Union 25 (EU-25) Member States to (1) establish and implement strategies to incre
Autor:
Ryoko Krause, Bram Palache
Publikováno v:
Expert review of vaccines. 8(4)
With the ongoing widespread circulation of avian H5N1 influenza viruses and the threat of pandemic influenza an ever-present reality, it is essential that those charged with protecting public health continue to focus intently on this urgent issue. As
Autor:
Bram Palache
Publikováno v:
Vaccine. 26(49)
Inactivated influenza vaccines have been available since the late 1940s for the prevention of influenza disease. Based on the available scientific evidence, many public health authorities, including the World Health Organization, recommend annual use
Publikováno v:
Vaccine. 26(1)
In a randomized, observer-blind, three-arm, parallel group, multi-centre trial including 386 elderly subjects in four countries, the immunogenicity and safety was studied of three different trivalent inactivated surface antigen (subunit) influenza va